肌电生物反馈治疗脑卒中患者运动功能障碍的效果观察

Observation on the efficacy of electromyographic biofeedback treatment on motor dysfunction in stroke patients

目的探究肌电生物反馈治疗脑卒中患者运动功能障碍的效果。方法选取2021年2月至2022年2月遵义医科大学第三附属医院收治的100例脑卒中患者作为研究对象,随机分为观察组和对照组,每组各50例。两组分别予以不同的治疗,比较两组运动功能评定量表(Fugl-Meyer)、功能性步行量表(FAC)、美国国立卫生院神经功能缺损量表(NIHSS)、日常活动能力指数评定量表(BI)、计时-起立-行走量表(TUG)、Berg平衡量表(BBS)、临床痉挛指数(CSI)评分。结果观察组Fugl-Meyer、BBS、FAC、BI评分均高于对照组,而TUG、NIHSS、CSI评分均低于对照组,差异有统计学意义(P<0.05)。结论肌电生物反馈治疗脑卒中患者效果显著,能够使其运动功能障碍得到改善,值得研究和推广。

Objective To explore the efficacy of electromyographic biofeedback treatment on motor dysfunction in stroke patients.Methods A total of 100 stroke patients admitted to the Third Affiliated Hospital of Zunyi Medical University from February 2021 to February 2022 were selected as the subjects and were randomly divided into an observation group and a control group,with 50 subjects in each group.Two groups were treated differently,scores of the motor function assessment scale(Fugl-Meyer),the functional walking scale(FAC),the neurological deficiency scale(NIHSS),the daily activity index rating scale(BI)for activities of daily living,the timekeeping-standing-walking meter(TUG),Berg balance scale(BBS)and clinical spasm index(CSI)were compared between the two groups.Results The Fugl Meyer,BBS,FAC,and BI scores of the observation group were higher than those of the control group,while the TUG,NIHSS,and CSI scores were lower than those of the control group,with statistically significant differences(P<0.05).Conclusion Electromyographic biofeedback has a significant efficacy on stroke patients and can improve their motor dysfunction,which is worthy of study and implementation.